Metachromatic Leukodystrophy has emerging NIH research funding with 3 grants totaling $5.2M.
1 new grant started in the last 12 months.
1 additional grant classified as “Other” (multi-disciplinary, infrastructure, etc.).
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Metachromatic Leukodystrophy. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
11 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for metachromatic leukodystrophy. Existing research activity suggests this may be a viable area for grant applications.
15 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for metachromatic leukodystrophy. Existing research activity suggests this may be a viable area for grant applications.
18 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for metachromatic leukodystrophy. Existing research activity suggests this may be a viable area for grant applications.
17 publications in Gene Therapy / Novel Therapeutics but no NIH-funded grants found in Translational / Drug Development for metachromatic leukodystrophy. Existing research activity suggests this may be a viable area for grant applications.
These grants mention Metachromatic Leukodystrophy as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Track funding opportunities for Metachromatic Leukodystrophy.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.